1 School of Public Health, Health Sciences University of Mongolia
:Health Sciences University of Mongolia
Өгүүллийн PDF-ийг татах
Coronary heart disease is the most frequent cause of death. Over the last 15 years, cardiovascular diseases have been the leading cause of mortality in Mongolia. Early management of patients with acute coronary syndrome reduces morbidity and mortality. The objective of this study was to investigate socio-demographic characteristics, clinical features, diagnosis and treatment among inpatients receiving tertiary level medical care for coronary heart disease.
We performed a cross-sectional study. The study was conducted among inpatients in urban and rural hospitals. Total sample size was 269. The most patients were male in either urban (74.1%) or rural (83.7%) hospitals. The mean age of patients was 58.7±11.3 and 50.311.4 in urban and rural hospitals, respectively. The majority of the patients had unstable angina in both hospitals. However, the urban hospitals had more patients with acute myocardial infarction than the rural hospitals. The length of stay ofpatients in rural hospitals was 12.1 ±3.3 (greater than in urban hospitals). Alcohol consumption among patients in rural hospitals was higher than urban hospitals (p<0.008). Only 25.5% and 46.9% ofpatients in urban and rural hospitals, respectively, were tested with lactodehydrogenaza. A substantial proportion ofpatients with acute coronary syndromes received aspirin, heparin, beta-blocker, and ACE inhibitors. In conclusion, elderly and male patients are more likely to have cardiovascular diseases, especially coronary heart disease. There was a lack of clinical laboratory and instrumental diagnosis of coronary heart diseases in both rural and urban hospitals. Biochemical cardio markers were not tested in almost all cases. Daily electrocardiograph monitoring was not done among patients with acute myocardial infarction. A relatively high percentage ofpatients with acute coronary syndrome were given appropriate drugs.
1. Reddy, K.S; Yusuf, S. 1998, Emerging Epidemic of Cardiovascular Disease in Developing Countries, Circulation Vol. 97, no:6, pp. 596-601
2. Kuulasmaa K, Tunstall PH, Dobson AJ, et al. 2000, Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA project. Lancet.Vol. 355, pp.675-687
3. Unal B, Critchley JA, Capewell S. 2004,
Explaining the Decline in Coronary Heart Disease
Mortality in England and Wales Between 1981
and 2000 Circulation. Vol. 109, pp.1101-1107
4. Tunstall-Pedoe H, Kuulasmaa K, Mahonen M,
et al. 1999, Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring Trends and Determinants in Cardiovascular Disease.Lancet. Vol. 353, pp. 1547-1557
10 Delgermaa et ai Quality of care: Diagnosis and treating coronary heart diseases
5. Collins R, Peto R, MacMahon S, et al. 1990, Blood pressure, stroke and coronary heart disease. Short term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet. Vol. 335, pp.827-838
6. Antiplatelet Trialists\' Collaboration. 1994, Collaborative overview of randomized trials of antiplatelet therapy—I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ. Vol.308, pp.81 -106
7. S. Capewell, J. P. Pell, C. Morrison and J. McMurray. 1999, Increasing the impact of cardiological treatments: How best to reduce deaths. European Heart Journal. Vol. 20, pp. 1386-1392
8. Ministry of Health of Mongolia. National Center
for Health Development. 2006, Health indicators 2005, Ulaanbaatar. pp.31 -37
9. Eugene B, Robert H.J, Daniel B.M, Jay B, Leslie
B, Melvin D.C et al. 1994, Diagnosing and Managing Unstable Angina. Circulation. Vol. 90, pp.613-622
10.The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. 2003, Management of acute myocardial infarction in patients presenting with ST-segment elevation. European Heart Journal. Vol. 24, pp. 28-66
ll.D G Julian, R M Norris. 2002, Myocardial infarction: is evidence-based medicine the best? Lancet. Vol. 359, pp.1515-1516
I2.S Capewell, B Unal, J A Critchley and J Mc Murray. 2006, Over 20 000 avoidable coronary deaths in England and Wales in 2000: the failure to give effective treatments to many eligible patients Heart. Vol. 92, pp.521-523
13.D. Hasdail, S. Behar, L. Wallentin, N. Danchin, A. K. Gitt, E. Boersma et al. 2002, A \\ prospective survey of the characteristics, treatments and outcomes of patients with acute coronary syndromes in Europe and the Mediterranean basin. The Euro Heart Survey of Acute Coronary Syndromes. European Heart Journal. Vol. 23, pp.1190-1201
